Abstract
Acetylcholinesterase inhibitors are currently of high interest due to the many reasons. Among them, Alzheimers disease drugs are of great interest. In this study, eleven monoquaternary pyridinium salts substituted by different groups (electron donors and electron acceptors) in position four were prepared. Then, their anticholinesterase activity was tested. As observed, their IC50s ranged from 33 μM to 3981 μM. Moreover, probability of blood-brain barrier penetration was predicted.
Keywords: Quaternary ammonium salts, pyridinium salts, inhibitor, cholinesterase, Alzheimer's disease, prophylaxis
Letters in Organic Chemistry
Title: Preparation and In Vitro Evaluation of Monoquaternary Inhibitors of Brain Cholinesterases
Volume: 6 Issue: 6
Author(s): Daniel Jun, Martin Paar, Jiri Binder, Jan Marek, Miroslav Pohanka, Petr Stodulka and Kamil Kuca
Affiliation:
Keywords: Quaternary ammonium salts, pyridinium salts, inhibitor, cholinesterase, Alzheimer's disease, prophylaxis
Abstract: Acetylcholinesterase inhibitors are currently of high interest due to the many reasons. Among them, Alzheimers disease drugs are of great interest. In this study, eleven monoquaternary pyridinium salts substituted by different groups (electron donors and electron acceptors) in position four were prepared. Then, their anticholinesterase activity was tested. As observed, their IC50s ranged from 33 μM to 3981 μM. Moreover, probability of blood-brain barrier penetration was predicted.
Export Options
About this article
Cite this article as:
Jun Daniel, Paar Martin, Binder Jiri, Marek Jan, Pohanka Miroslav, Stodulka Petr and Kuca Kamil, Preparation and In Vitro Evaluation of Monoquaternary Inhibitors of Brain Cholinesterases, Letters in Organic Chemistry 2009; 6 (6) . https://dx.doi.org/10.2174/157017809789124876
DOI https://dx.doi.org/10.2174/157017809789124876 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Polypharmacology of Approved Anticancer Drugs
Current Drug Targets Depression, Antidepressants and Hypertensive Disorders of Pregnancy: A Systematic Review
Current Drug Safety Current Drug Targets and Future Therapy of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Smoking and Weight
Current Respiratory Medicine Reviews Stroke Induced Immunodepression Syndrome: From Bench to Bedside
Current Molecular Medicine Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model
Current Alzheimer Research <i>Cannabis Sativa</i> L. Flower and Bud Extracts Inhibited <i>In vitro</i> Cholinesterases and β-Secretase Enzymes Activities: Possible Mechanisms of Cannabis Use in Alzheimer Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Aquaporin 4 in Astrocytes is a Target for Therapy in Alzheimer's Disease
Current Pharmaceutical Design Current In Vitro High Throughput Screening Approaches to Assess Nuclear Receptor Activation
Current Drug Metabolism A comparative <i>in vivo</i> Evaluation of Anti-Alzheimer Activity of Bacopa Extract and its Solid Lipid Nanoparticles
Current Bioactive Compounds Microdose Lithium Treatment Stabilized Cognitive Impairment in Patients with Alzheimer’s Disease
Current Alzheimer Research Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Cell Hierarchy, Metabolic Flexibility and Systems Approaches to Cancer Treatment
Current Pharmaceutical Biotechnology Safeguarding Childrens Rights in Psychopharmacological Research: Ethical and Legal Issues
Current Pharmaceutical Design Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications
Current Pharmaceutical Design Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 Channels
Current Pharmaceutical Biotechnology Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
Current Medicinal Chemistry Prion Protein Oligomerization
Current Alzheimer Research Nicotine Addiction and Coronary Artery Disease: Impact of Cessation Interventions
Current Pharmaceutical Design Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics